Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Theor Biol ; 288: 57-65, 2011 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-21872606

RESUMEN

Understanding the spatial patterns of genetic diversity and what causes them is an important outstanding question in ecology. Here we investigate the roles of spatial heterogeneity and system area in generating genome diversity, and study its dependence with sampled area. We study an individual-based model that incorporates natural selection on the habitat type and compare the effects of asexual and sexual reproductions. A key ingredient of the model is the possibility to tune the level of spatial heterogeneity among the habitats. Our results corroborate either the bi-phasic or tri-phasic scenarios, one phase corresponding to a power law regime, for the diversity-area relationship in both sexual and asexual populations, being the shape of the curve influenced by mutation rates and spatial correlation. These observations are verified for distinct sets of parameter values.


Asunto(s)
Variación Genética , Modelos Genéticos , Animales , Ecosistema , Epistasis Genética , Tasa de Mutación , Reproducción/genética , Reproducción Asexuada/genética , Selección Genética/genética
2.
Nephron ; 137(1): 38-46, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28609764

RESUMEN

BACKGROUND/AIM: Onychomycosis (OM) is one of the commonest superficial fungal infections. Patients undergoing hemodialysis (HD) treatment and kidney transplant recipients (KTR) are considered at risk of contracting fungal infections, but the few published data do not reach the conclusion of whether they are predisposed to OM. This study aimed to determine the prevalence and etiology of OM in these patients and to determine the antifungal susceptibility profile of the isolated fungal species. METHODS: We recruited 149 HD patients, 187 KTR, and a control group comprising 174 patients attending an internal medicine service with other diseases than renal diseases. All patients underwent an examination of all toenails to check for the presence of OM. Antifungal susceptibility tests were performed following the Clinical and Laboratory Standards Institute (CLSI) recommendations. RESULTS: The prevalence rates of OM in HD patients (23.4%) and KTR (23.0%) were significantly higher than those in age- and sex-matched control groups (13.2%). In HD patients, OM was associated with diabetes but not with the duration of dialysis. In KTR, OM was more prevalent in those without diabetes and likely also in those using mycophenolate mofetil or azathioprine but was not associated with the duration of transplantation. Trichophyton rubrum was the most prevalent species (45.9%) followed by T. mentagrophytes (24.5%) and Candida parapsilosis (18.0%). Fluconazole, itraconazole, voriconazole, and terbinafine were all efficient against the isolates of dermatophyte, with terbinafine showing the lowest and fluconazole the highest minimal inhibitory concentrations. All isolates of C. parapsilosis were sensitive to the antifungals according to the CLSI criteria. CONCLUSION: We found a high prevalence of OM in HD and KTR patients and suggest that these conditions should be considered a risk factor of OM. All 4 antifungals evaluated in the study showed good in vitro activity against the etiologic agents.


Asunto(s)
Dermatosis del Pie/etiología , Trasplante de Riñón/efectos adversos , Onicomicosis/etiología , Diálisis Renal/efectos adversos , Adulto , Antifúngicos/farmacología , Candida parapsilosis/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Candidiasis/etiología , Candidiasis/microbiología , Susceptibilidad a Enfermedades , Femenino , Dermatosis del Pie/tratamiento farmacológico , Dermatosis del Pie/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Onicomicosis/tratamiento farmacológico , Onicomicosis/microbiología , Factores de Riesgo , Tiña/tratamiento farmacológico , Tiña/etiología , Tiña/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA